Calix Limited
ASX: CXL
Narrower losses and strong contract momentum.
(Source: TradingView) 3-Month Performance Profile of CXL on a DTF compared to S&P/ASX 200 (XJO).
Calix Limited’s FY25 performance showed meaningful progress, with net losses narrowing 24.11% YoY to $19.17 million, supported by stronger Magnesia product momentum. New and renewed contracts in Australia and the US co
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
